Genomenon, Inc.

Genomenon is a genomics intelligence company in the lead position to be the first to curate the entire human genome. Our team is dedicated to improving the quality of patients' lives by characterizing the genomic drivers of genetic disease and cancer. Genomenon's curation process emphasizes the clinical relevance of genetic findings, ensuring that curated data directly supports accurate diagnosis and effective treatment decisions. Blending the power of AI with the precision of genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development.

Genomenon empowers scientists, researchers and clinicians at pharmaceutical companies, clinical labs, and universities to more thoroughly understand diseases at a molecular level. Expertise in Genomics Our team of genetic scientists and expert curators review scientific publications and leverage our genomics focused artificial intelligence to analyze and interpret vast amounts of genomic data. This expertise enables us to provide unparalleled genomic insights that support patient diagnosis and precision medicine development.

• Software: Genomenon's Mastermind Genomic Intelligence Platform is the world's most comprehensive genomic database. It supports research & helps diagnostic companies accelerate their workflow.
• Data: Gain access to Genomenon's expansive, constantly updated database of curated genomic data without leaving your existing workflow.
• Services: Our expert team provides tailored consulting services to support your genomic projects.